Nitroxide Antioxidant UCP3 Gene Expression Modulation

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

There is a need to effectively increase the expression levels of uncoupling protein 3 (UCP3) in human subjects, particularly those over 35, to treat and prevent diseases associated with its underexpression, such as cancer, autoimmune diseases, and age-related conditions, as natural control of gene expression deteriorates with age leading to various health issues.

Innovation Solution

Administering an effective amount of a nitroxide antioxidant, specifically 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl, to human subjects with decreased UCP3 expression levels, either age-related or disease-related, to increase the expression level of UCP3 in tissues like skin, adipose, and neuronal tissues.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If natural control mechanisms are relied upon, then gene expression is normally regulated, but with aging the natural control deteriorates leading to underexpression of UCP3

Engineering Contradiction:

Improvenatural control of gene expressionVSAvoidUCP3 expression level

Core Design Contradiction:

ReliabilityVSQuantity of substance

Solution Approach 1:

The patent introduces nitroxide antioxidants as intermediary substances that mediate between the aging process and UCP3 gene expression. These compounds act as mediators that restore the deteriorating natural control mechanisms by directly influencing gene expression levels, thereby compensating for the age-related decline in endogenous regulation capacity

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent applies parameter changes by modifying the chemical environment through nitroxide antioxidant administration. This changes the physiological parameters (oxidative stress levels, gene expression profiles) to restore UCP3 expression to appropriate levels, effectively reversing the age-related parameter deterioration

Inventive Principle:

Principle #35Parameter changes

2Quantity of substance

If nitroxide antioxidants are administered to increase UCP3 expression, then gene expression levels improve, but the complexity of treatment increases

Engineering Contradiction:

ImproveUCP3 expression levelVSAvoidtreatment complexity

Core Design Contradiction:

Quantity of substanceVSDevice complexity

Solution Approach 1:

The nitroxide antioxidants enable a form of self-service treatment where the administered compound works through natural biological pathways to restore gene expression. The treatment leverages the body's own gene regulatory mechanisms rather than requiring complex external intervention systems, simplifying the overall treatment approach despite the need for compound administration

Inventive Principle:

Principle #25Self-service

Data Source

PatentUS20220378766A1Modulating expression level of a gene encoding an uncoupling protein by treating a human subject with a nitroxide

Publication Date: 2022.12.01 HABASH LOUIS

AI summary

Some embodiments disclosed herein include a method for increasing an expression level of a gene. The methods include identifying a human subject having a decreased expression level of UCP3; and administering to the human subject an effective amount of a nitroxide antioxidant, whereby expression level of the gene is increased.